Precigen (PGEN) Liabilities from Discontinued Operations (2018 - 2022)
Precigen (PGEN) reported Liabilities from Discontinued Operations of 11448000.0 for Q2 2022, up 11123.53% year-over-year from N/an in Q2 2021, and down 10.92% quarter-over-quarter from 12851000.0 in Q4 2021.
Precigen (PGEN) Liabilities from Discontinued Operations (2018 - 2022) Analysis & Trends
Precigen (PGEN) has 5 years of Liabilities from Discontinued Operations data on file, last reported at 11448000.0 in Q2 2022.
- Liabilities from Discontinued Operations for Q2 2022 came in at 11448000.0, up 11123.53% year-over-year; the trailing twelve-month figure through Jun 2022 was 11448000.0 (up 11123.53% YoY), and the FY2021 annual result was 12851000.0, down 8.51% from the prior year.
- Liabilities from Discontinued Operations eased to 11448000.0 in Q2 2022 per PGEN's latest filing, from 12851000.0 in the prior quarter.
- Over five years, Liabilities from Discontinued Operations peaked at 50538000.0 in Q4 2019 and troughed at 102000.0 in Q2 2021.
- A 5-year average of 13928285.71 and a median of 11448000.0 in 2022 frame the typical range for Liabilities from Discontinued Operations.
- The sharpest annual moves came in 2020 and 2022: Liabilities from Discontinued Operations plunged 72.21% in 2020, then surged 11123.53% in 2022.
- A 5-year view of Liabilities from Discontinued Operations shows it stood at 8340000.0 in 2018, then soared by 505.97% to 50538000.0 in 2019, then sank by 72.21% to 14047000.0 in 2020, then decreased by 8.51% to 12851000.0 in 2021, then declined by 10.92% to 11448000.0 in 2022.
- Business Quant data shows PGEN's Liabilities from Discontinued Operations at 11448000.0 in Q2 2022, 12851000.0 in Q4 2021, and 102000.0 in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 11.45 Mn |
| Jun 30, 2022 | 11.45 Mn |
| Dec 31, 2021 | 12.85 Mn |
| Dec 31, 2021 | 12.85 Mn |
| Jun 30, 2021 | 102,000.00 |
| Jun 30, 2021 | 102,000.00 |
| Mar 31, 2021 | 172,000.00 |
| Mar 31, 2021 | 172,000.00 |
| Dec 31, 2020 | 14.05 Mn |
| Dec 31, 2020 | 14.05 Mn |
| Dec 31, 2019 | 50.54 Mn |
| Dec 31, 2019 | 50.54 Mn |
| Dec 31, 2018 | 8.34 Mn |
| Dec 31, 2018 | 8.34 Mn |